Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer.
exosomes
liquid biopsies
prediction
therapeutic targeting
tumor progression
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
28 Sep 2023
28 Sep 2023
Historique:
received:
15
07
2023
revised:
02
09
2023
accepted:
03
09
2023
medline:
1
11
2023
pubmed:
14
10
2023
entrez:
14
10
2023
Statut:
epublish
Résumé
Extracellular vesicles (EVs)-including apoptotic bodies, microvesicles, and exosomes-are released by almost all cell types and contain molecular footprints from their cell of origin, including lipids, proteins, metabolites, RNA, and DNA. They have been successfully isolated from blood, urine, semen, and other body fluids. In this review, we discuss the current understanding of the predictive value of EVs in prostate and renal cancer. We also describe the findings supporting the use of EVs from liquid biopsies in stratifying high-risk prostate/kidney cancer and advanced disease, such as castration-resistant (CRPC) and neuroendocrine prostate cancer (NEPC) as well as metastatic renal cell carcinoma (RCC). Assays based on EVs isolated from urine and blood have the potential to serve as highly sensitive diagnostic studies as well as predictive measures of tumor recurrence in patients with prostate and renal cancers. Overall, we discuss the biogenesis, isolation, liquid-biopsy, and therapeutic applications of EVs in CRPC, NEPC, and RCC.
Identifiants
pubmed: 37834162
pii: ijms241914713
doi: 10.3390/ijms241914713
pmc: PMC10573190
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
PLoS One. 2010 Jan 05;5(1):e8577
pubmed: 20052414
Proteomics. 2012 Jan;12(2):329-38
pubmed: 22106071
Nat Cell Biol. 2008 Dec;10(12):1470-6
pubmed: 19011622
J Transl Med. 2012 Mar 22;10:55
pubmed: 22440013
Sci Rep. 2021 Apr 1;11(1):7355
pubmed: 33795765
Comput Math Methods Med. 2021 May 24;2021:5517747
pubmed: 34122615
J Extracell Vesicles. 2021 Dec;10(14):e12144
pubmed: 34919343
Eur Urol. 2019 May;75(5):752-763
pubmed: 30293904
Cancers (Basel). 2022 Sep 07;14(18):
pubmed: 36139519
Clin Cancer Res. 2019 Nov 1;25(21):6532-6545
pubmed: 31371344
Oncol Lett. 2018 Apr;15(4):6003-6008
pubmed: 29552228
Cancer Epidemiol. 2012 Aug;36(4):391-4
pubmed: 22542158
Cancer Lett. 2017 Dec 1;410:100-111
pubmed: 28935391
Int J Mol Sci. 2023 Jun 29;24(13):
pubmed: 37446024
Heliyon. 2020 Jul 02;6(7):e04138
pubmed: 32642575
Biochim Biophys Acta Rev Cancer. 2018 Dec;1870(2):274-282
pubmed: 29852194
JAMA Oncol. 2016 Jul 1;2(7):882-9
pubmed: 27032035
J Biochem Mol Toxicol. 2018 May 2;:e22158
pubmed: 29719090
Oncotarget. 2020 Dec 22;11(51):4681-4692
pubmed: 33473254
Sci Stud Read. 2016;20(1):20-33
pubmed: 26770056
Clin Genitourin Cancer. 2020 Aug;18(4):322-331.e2
pubmed: 32046920
Nucleic Acids Res. 2012 Nov;40(21):10937-49
pubmed: 22965126
Front Mol Biosci. 2020 Jan 31;6:160
pubmed: 32118030
Adv Exp Med Biol. 2022;1361:235-247
pubmed: 35230692
Prostate. 2014 Sep;74(13):1320-34
pubmed: 25053345
Prostate. 2017 May;77(6):573-583
pubmed: 27990656
BJU Int. 2016 Feb;117(2):260-5
pubmed: 25307281
Cells. 2020 Apr 02;9(4):
pubmed: 32252322
Clin Genitourin Cancer. 2019 Apr;17(2):e345-e355
pubmed: 30528378
J Natl Compr Canc Netw. 2022 Jan;20(1):71-90
pubmed: 34991070
Pathol Res Pract. 2021 Nov;227:153625
pubmed: 34628264
BJOG. 2009 Jan;116(2):152-7
pubmed: 19076946
Actas Urol Esp (Engl Ed). 2020 Apr;44(3):139-147
pubmed: 31839360
Med J Islam Repub Iran. 2020 Aug 04;34:91
pubmed: 33306056
Exp Mol Pathol. 2013 Feb;94(1):115-20
pubmed: 23064048
Br J Cancer. 2009 May 19;100(10):1603-7
pubmed: 19401683
BJU Int. 2019 Oct;124(4):693-700
pubmed: 31055861
Eur Urol Focus. 2018 Apr;4(3):412-419
pubmed: 28753793
Sci Rep. 2020 Jul 28;10(1):12564
pubmed: 32724107
Cancers (Basel). 2021 Jul 28;13(15):
pubmed: 34359692
Science. 2008 Feb 29;319(5867):1244-7
pubmed: 18309083
Sci Rep. 2019 Sep 24;9(1):13772
pubmed: 31551516
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Int J Urol. 2022 May;29(5):462-469
pubmed: 35184335
Drug Discov Today. 2020 Sep 20;:
pubmed: 32966866
Front Oncol. 2020 May 07;10:724
pubmed: 32457844
J Cancer. 2016 Jul 05;7(11):1452-64
pubmed: 27471561
Curr Drug Targets. 2019;20(14):1447-1460
pubmed: 31284859
Mol Cancer. 2019 Apr 11;18(1):86
pubmed: 30975145
Front Cell Dev Biol. 2018 Feb 20;6:18
pubmed: 29515996
Breast Cancer. 2018 Mar;25(2):198-205
pubmed: 29101635
Biochim Biophys Acta. 1981 Jul 6;645(1):63-70
pubmed: 6266476
Eur Urol. 2022 Jan;81(1):125-127
pubmed: 34794853
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Nat Rev Cancer. 2015 Dec;15(12):701-11
pubmed: 26563462
Cancers (Basel). 2022 Feb 09;14(4):
pubmed: 35205607
Mol Cancer. 2019 Apr 2;18(1):75
pubmed: 30940145
Biochem Biophys Res Commun. 2017 Oct 21;492(3):356-361
pubmed: 28851650
Histopathology. 2012 Jan;60(1):59-74
pubmed: 22212078
Nat Rev Urol. 2021 Oct;18(10):581-596
pubmed: 34290447
Cancer Res. 1990 Jun 15;50(12):3748-53
pubmed: 2340521
Endocr Relat Cancer. 2020 May;27(5):R133-R144
pubmed: 32203935
Eur Urol. 2016 Apr;69(4):660-673
pubmed: 26323946
Cancer Res. 2023 Jan 4;83(1):103-116
pubmed: 36264173
Cancers (Basel). 2013 Dec 04;5(4):1676-90
pubmed: 24305656
Sci Rep. 2016 Aug 09;6:30386
pubmed: 27503267
Cancer Sci. 2021 Aug;112(8):3363-3374
pubmed: 34009695
Prostate. 2019 Nov;79(15):1767-1776
pubmed: 31475741
Cancer Lett. 2018 Apr 10;419:128-138
pubmed: 29353077
Oncotarget. 2015 Oct 6;6(30):30357-76
pubmed: 26196085
Eur Urol. 2022 Oct;82(4):399-410
pubmed: 35346519
Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1690-1692
pubmed: 29440440
Prostate Cancer Prostatic Dis. 2004;7(1):21-31
pubmed: 14999234
Proteomics. 2013 May;13(10-11):1667-1671
pubmed: 23533145
Cancer Res. 2018 Apr 1;78(7):1833-1844
pubmed: 29437039
J Extracell Vesicles. 2020 May 20;9(1):1763594
pubmed: 32595914
Int J Clin Exp Pathol. 2010 Oct 16;3(8):775-81
pubmed: 21151391
Mol Med Rep. 2013 Jul;8(1):272-6
pubmed: 23652371
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
Oncotarget. 2016 Nov 8;7(45):72593-72607
pubmed: 27683042
Curr Opin Cell Biol. 2014 Aug;29:116-25
pubmed: 24959705
Nat Commun. 2018 Dec 19;9(1):5395
pubmed: 30568162
Exp Ther Med. 2019 Apr;17(4):2457-2464
pubmed: 30906433
J Dev Biol. 2021 Nov 29;9(4):
pubmed: 34940501
Mol Cancer. 2023 Feb 21;22(1):37
pubmed: 36810071
Expert Rev Proteomics. 2009 Jun;6(3):267-83
pubmed: 19489699
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11428-11436
pubmed: 31061129
Nature. 2015 Nov 19;527(7578):329-35
pubmed: 26524530
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
J Cell Biochem. 2017 Jan;118(1):66-73
pubmed: 27232975
Cancer Cell. 2016 Aug 8;30(2):243-256
pubmed: 27505671
Clin Genitourin Cancer. 2016 Oct;14(5):e515-e520
pubmed: 27150639
Science. 1991 Nov 22;254(5035):1138-46
pubmed: 1659741
Oncotarget. 2016 Feb 23;7(8):8839-49
pubmed: 26814433
Int J Mol Sci. 2013 Apr 10;14(4):7757-70
pubmed: 23574937
Science. 2020 Feb 7;367(6478):
pubmed: 32029601
Front Oncol. 2018 Jun 13;8:222
pubmed: 29951375
J Am Coll Radiol. 2018 Feb;15(2):264-273
pubmed: 28651987
Front Oncol. 2019 Dec 06;9:1370
pubmed: 31921634
J Cell Mol Med. 2019 Oct;23(10):6755-6765
pubmed: 31342628
Nature. 2019 Jun;570(7761):385-389
pubmed: 31142840
J Clin Oncol. 2014 Oct 20;32(30):3383-90
pubmed: 25225419
Urol Int. 2013;91(3):273-8
pubmed: 23860338
Sci Rep. 2021 Apr 15;11(1):8279
pubmed: 33859239
Cancer. 2000 Aug 1;89(3):604-14
pubmed: 10931460
Front Mol Biosci. 2023 May 17;10:1156821
pubmed: 37266331
Transl Res. 2021 Apr;230:164-196
pubmed: 33253979
Eur Urol. 2017 Apr;71(4):680-687
pubmed: 27733296
Expert Rev Proteomics. 2017 Jan;14(1):69-95
pubmed: 27838931
Can Urol Assoc J. 2021 Apr;15(4):132-137
pubmed: 33007184
Front Cell Dev Biol. 2021 Jan 07;8:602493
pubmed: 33490068
Cancer Med. 2021 Sep;10(18):6282-6290
pubmed: 34318630
Br J Cancer. 2022 Feb;126(3):492-501
pubmed: 34811506
Oncotarget. 2018 Apr 10;9(27):19283-19293
pubmed: 29721202
Carcinogenesis. 2020 May 14;41(3):274-283
pubmed: 31605605
Cell Death Dis. 2018 Aug 28;9(9):854
pubmed: 30154401
PLoS One. 2011;6(9):e25787
pubmed: 21984948
Thorac Cancer. 2014 Nov;5(6):500-8
pubmed: 26767044
Invest New Drugs. 2020 Jun;38(3):746-754
pubmed: 31312936
J Transl Med. 2018 Jan 9;16(1):1
pubmed: 29316942
Lab Invest. 2009 Nov;89(11):1317-28
pubmed: 19786948
J Cell Biochem. 2019 Feb;120(2):1492-1502
pubmed: 30304555
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Eur Urol Oncol. 2021 Dec;4(6):893-903
pubmed: 33975782
Mol Biosyst. 2013 Jun;9(6):1220-33
pubmed: 23511837
Oncogene. 2020 Sep;39(39):6203-6217
pubmed: 32826950
Proc Natl Acad Sci U S A. 2011 May 24;108(21):8809-14
pubmed: 21555566
Int J Mol Sci. 2019 Apr 13;20(8):
pubmed: 31013896
Endocr Rev. 2022 May 12;43(3):441-468
pubmed: 35552682
Br J Cancer. 2020 Mar;122(6):801-811
pubmed: 31937922
Int J Mol Sci. 2020 Mar 19;21(6):
pubmed: 32204455
Cancers (Basel). 2021 Jul 05;13(13):
pubmed: 34282798
iScience. 2022 May 18;25(6):104414
pubmed: 35663013
Front Oncol. 2022 Dec 21;12:1066288
pubmed: 36620603
J Natl Cancer Inst. 1975 May;54(5):1137-48
pubmed: 165305
Int J Clin Exp Pathol. 2017 Oct 01;10(10):10618-10626
pubmed: 31966404
Curr Oncol Rep. 2021 Jan 12;23(2):15
pubmed: 33433737
Dis Markers. 2016;2016:3693096
pubmed: 27725787
Mol Cancer. 2019 Mar 1;18(1):32
pubmed: 30823926
Biochim Biophys Acta. 1985 Sep 9;822(2):203-18
pubmed: 2992593
Crit Rev Oncol Hematol. 2021 Nov;167:103495
pubmed: 34655743
Eur Urol. 2015 Jan;67(1):33-41
pubmed: 25129854
PLoS One. 2016 May 04;11(5):e0154507
pubmed: 27144529
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Jun;160(2):183-94
pubmed: 26558360
Signal Transduct Target Ther. 2020 Oct 19;5(1):242
pubmed: 33077737
Tumour Biol. 2014 May;35(5):4057-66
pubmed: 24379138
Annu Rev Biochem. 2019 Jun 20;88:487-514
pubmed: 31220978
Target Oncol. 2020 Jun;15(3):261-278
pubmed: 32451752
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Front Mol Biosci. 2022 Jan 04;8:796385
pubmed: 35059436
Eur Urol Focus. 2016 Jun;2(2):210-218
pubmed: 28723537
Andrologia. 1978 Jul-Aug;10(4):261-72
pubmed: 152589
Cancer Manag Res. 2021 Nov 02;13:8257-8271
pubmed: 34754245
Mol Cell Proteomics. 2010 Feb;9(2):197-208
pubmed: 19837982
Br J Cancer. 1972 Aug;26(4):239-57
pubmed: 4561027
Cancer Cell. 2016 May 9;29(5):653-668
pubmed: 27117758
Nat Med. 2020 Jul;26(7):1041-1043
pubmed: 32572266
Transl Androl Urol. 2021 Apr;10(4):1890-1907
pubmed: 33968677
Front Mol Biosci. 2017 Jun 07;4:37
pubmed: 28638822
Int J Mol Sci. 2020 Aug 19;21(17):
pubmed: 32824915
Int J Cancer. 2018 Feb 1;142(3):607-617
pubmed: 28975613
Curr Opin Cell Biol. 2009 Aug;21(4):575-81
pubmed: 19442504
Pol Arch Intern Med. 2021 Jun 29;131(6):582-585
pubmed: 34018710
Mol Cancer. 2019 Mar 30;18(1):55
pubmed: 30925923
Mol Cancer. 2016 May 18;15(1):41
pubmed: 27189160
Sci Rep. 2021 Mar 10;11(1):5600
pubmed: 33692449
Onco Targets Ther. 2022 Aug 26;15:897-912
pubmed: 36051571
J Urol. 2007 Jul;178(1):88-92
pubmed: 17499308
Genet Med. 2020 Aug;22(8):1366-1373
pubmed: 32341571
Int J Oncol. 2014 Jan;44(1):53-8
pubmed: 24212760
BMC Cancer. 2017 Nov 09;17(1):730
pubmed: 29121858
Nat Rev Nephrol. 2022 Aug;18(8):499-513
pubmed: 35641620
Cancers (Basel). 2020 May 09;12(5):
pubmed: 32397507
Clin Epigenetics. 2018 Jan 23;10:11
pubmed: 29410711
Urol Oncol. 2016 Mar;34(3):147-55
pubmed: 26094171
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):E8987-E8995
pubmed: 29073095
J Cancer. 2016 Sep 27;7(14):1960-1967
pubmed: 27877211
BJU Int. 2022 Mar;129(3):290-303
pubmed: 34570419
Crit Rev Oncol Hematol. 2020 Jan;145:102860
pubmed: 31874447
Cancer. 2012 Jan 1;118(1):82-90
pubmed: 21713763
Biomedicines. 2022 Dec 02;10(12):
pubmed: 36551871
Sci Rep. 2017 Feb 17;7:42961
pubmed: 28211531
Cancer Lett. 2017 Sep 10;403:318-329
pubmed: 28694142
J Urol. 2010 Apr;183(4):1309-15
pubmed: 20171681
Nat Rev Cancer. 2017 May;17(5):302-317
pubmed: 28303905
Abdom Radiol (NY). 2020 Jun;45(6):1896-1906
pubmed: 31894384
Int Urol Nephrol. 2018 May;50(5):851-859
pubmed: 29549624
Eur Urol Focus. 2022 Jul;8(4):904-906
pubmed: 36123280
Ups J Med Sci. 1983;88(2):63-80
pubmed: 6649193
Ann Oncol. 2015 Aug;26(8):1589-604
pubmed: 26041764
Cancers (Basel). 2021 Jan 11;13(2):
pubmed: 33440913
Front Oncol. 2022 May 20;12:863472
pubmed: 35669415
Eur Urol. 2016 Aug;70(2):312-22
pubmed: 26806656
J Proteome Res. 2010 May 7;9(5):2109-16
pubmed: 20334419
Diagnostics (Basel). 2020 Aug 17;10(8):
pubmed: 32824612
Int J Mol Sci. 2021 Sep 20;22(18):
pubmed: 34576294
IUCrJ. 2018 Jan 01;5(Pt 1):4-5
pubmed: 29354265
Int J Mol Sci. 2016 Oct 26;17(11):
pubmed: 27792187
J Extracell Vesicles. 2020 May 24;9(1):1761072
pubmed: 32922691
Sci Adv. 2020 Dec 9;6(50):
pubmed: 33298436
Eur J Cancer. 2010 Dec;46(18):3141-8
pubmed: 20709527
Front Cell Dev Biol. 2021 Jun 10;9:689947
pubmed: 34179017
Cancers (Basel). 2022 Jul 04;14(13):
pubmed: 35805043
Noncoding RNA. 2021 Dec 02;7(4):
pubmed: 34940756
Cancer Biomark. 2019;24(2):153-158
pubmed: 30689558